Rankings
▼
Calendar
DNLI FY 2025 Earnings — Denali Therapeutics Inc. Revenue & Financial Results | Market Cap Arena
DNLI
Denali Therapeutics Inc.
$3B
FY 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$11M
Operating Income
-$555M
Net Income
-$513M
EPS (Diluted)
$-2.97
Cash Flow
Operating Cash Flow
-$413M
Free Cash Flow
-$422M
Stock-Based Comp.
$100M
Balance Sheet
Total Assets
$1.1B
Total Liabilities
$131M
Stockholders' Equity
$1.0B
Cash & Equivalents
$205M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$11M
$0
—
Operating Income
-$555M
-$487M
-14.0%
Net Income
-$513M
-$423M
-21.2%
← Q4 2024
All Quarters
Q1 2025 →